Patent ID: 9376442
Filing Date: 2016-06-28
CPC Classification: A61P,C07D

Claim Text:
1. A method for treating idiopathic pulmonary lung fibrosis in a patient, comprising administering to said patient a therapeutically effective amount of a compound of formula (I) wherein R1 is —CH R2 is hydrogen, R21 is hydrogen, R22 is hydrogen, halogen, 1-4C-alkyl, 1-4C-alkoxy, —C(O)-1-4C-alkyl or 1-4C-fluoroalkyl, or R21 and R22 combine to form a group —O—CH R23 is hydrogen, halogen, 1-4C-alkoxy, R24 is hydrogen, Y is —(CH n is 0, R3 is a cyclohexyl or cyclopentyl group substituted by R6 and optionally substituted by R61, R6 is —NH—C(O)—R7, R61 is halogen or 1-4C-alkyl, R7 is 1-4C-alkyl, which is optionally substituted by R71, or R7 is 1-4C-alkoxy, R71 is 1-4C-alkoxy, or a salt thereof, a stereoisomer of the compound or a salt of the stereoisomer.